anticentromere antibody

Known as: ACA antibody 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1984-2017
02419842017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
OBJECTIVE To determine any associations of the PTPN22 R620W single-nucleotide polymorphism (SNP) with systemic sclerosis (SSc) or… (More)
Is this relevant?
2004
2004
OBJECTIVE Scleroderma is characterized by the presence of 3 predominant, yet almost mutually exclusive, antibodies… (More)
Is this relevant?
2001
2001
OBJECTIVE To determine whether the clinical and laboratory characteristics of anticentromere antibody (ACA) positive, anti-SSA/Ro… (More)
Is this relevant?
2000
2000
This study has estimated the cancer risk among patients with systemic sclerosis (SSc) using a population-based analysis. Using… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
1995
1995
OBJECTIVE To define further HLA class II gene associations with anticentromere antibody (ACA), a major serum antinuclear antibody… (More)
  • table 1
  • table 2
Is this relevant?
1989
1989
Anticentromere antibody (ACA) was previously described as a serological marker for CREST, progressive systemic sclerosis (PSS… (More)
Is this relevant?
Highly Cited
1988
Highly Cited
1988
Of 397 systemic sclerosis (scleroderma) patients from the University of Pittsburgh, who had serum determinations of both anti-Scl… (More)
Is this relevant?
1987
1987
To elucidate further the clinical significance of the anticentromere antibody (ACA), 32 Australian-born Caucasian patients with… (More)
Is this relevant?
Highly Cited
1986
Highly Cited
1986
Ninety patients who fulfilled the ARA criteria for systemic sclerosis were divided into 6 groups on the basis of cutaneous areas… (More)
Is this relevant?
1984
1984
Anticentromere antibody (ACA) was found in the serum of 4 (3%) of 120 patients with progressive systemic sclerosis with diffuse… (More)
Is this relevant?